Tuesday 11 October 2016

The findings from our genomic analysis of pancreatic NETs were presented by Dr Ben Lawrence today at ESMO, the annual meeting of the European Society for Medical Oncology, in Copenhagen, Denmark.

The presentation; “Pancreatic neuroendocrine tumour (pNET) profiles in the NETwork! programme: Clinic–enabled genomics for genomic-enabled clinical decisions” outlined key findings from the work the team has been progressing on pancreatic NETs. The annual ESMO meeting is the premier European scientific platform for presenting oncology research and, as such, acceptance of our abstract for presentation at this meeting is a testament to the dedication and hard work of all those involved.

See the ESMO write up of the presentation here